Loading...
XSHE
300313
Market cap401mUSD
Dec 05, Last price  
9.07CNY
1D
0.11%
1Q
11.29%
Jan 2017
-52.26%
IPO
22.28%
Name

Xinjiang Tianshan Animal Husbandry Bio-Engineering Co Ltd

Chart & Performance

D1W1MN
XSHE:300313 chart
P/E
P/S
20.63
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
-9.69%
Revenues
138m
+0.07%
22,304,24933,706,56452,518,48775,484,86282,003,49982,656,575121,943,044246,867,894375,207,065195,305,726105,225,957229,005,660163,309,323107,976,19576,350,268137,499,875137,601,816
Net income
-66m
L+199.74%
5,112,69710,415,74022,439,87727,025,00219,064,9879,615,7891,791,099007,444,331002,512,41300-22,001,636-65,947,904
CFO
14m
P
02,624,79515,775,51438,504,383003,184,3660121,655,16278,721,5660013,682,99200-13,747,71714,357,578
Dividend
May 08, 20150.05 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. engages in cattle and sheep breeding activities in China. The company engages in the improvement of cattle and sheep varieties, relying on biological genetic technology to provide embryo and other genetic materials and related services for the livestock industry. It is also involved in breeding, fattening, slaughtering, processing, and selling beef cattle; and slaughtering beef and mutton products. The company was founded in 2003 and is based in Changji, China.
IPO date
Apr 25, 2012
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT